In the News

3 Key Issues To Watch As Pricing Probes Swamp Big Pharma, Law360

November 09, 2015

The whirlwind of investigations into sky-high prescription drug prices has sucked in the world's largest drugmakers and cleared a path for legislation and regulation aimed at curbing costs, experts say.

Partner Stephen Paul Mahinka is quoted regarding the impact of the impending policy response.

Read the full story >>